bioRxivCell BiologyPreprint
MERLIN-DEFICIENT iPSCs AS AN IN VITRO MODEL SYSTEM FOR STUDIYNG NF2 PATHOGENESIS
N. Catasus, M. Torres-Martin, A. Negro, B. Kuebler, I. Rosas, G. Casals, H. Mazuelas, F. Roca-Ribas, E. Amilibia, B. Aran, A. Veiga, A. Raya, B. Gel Moreno, I. Blanco, E. Serra, M. Carrio, E. CASTELLANOS
Abstract
NF2-related schwannomatosis is an autosomal dominant syndrome that predisposes to the development of benign tumors of the nervous system. Schwannomas, particularly bilateral vestibular schwannomas (VS), are the most characteristic features of the disease. These tumors are caused by the bi-allelic inactivation of the NF2 gene in a cell of the Schwann cell lineage. Our current understanding of the molecular pathogenesis of the NF2 gene, as well as the development of new effective therapies is hampered by the absence of human non-perishable cell-based bearing distinct NF2 pathogenic variants. With this aim, we generated and characterized three isogenic paired induced pluripotent stem cell (iPSC) lines with single or bi-allelic inactivation of NF2 by combining the direct reprogramming of VS cells with the use of CRISPR/Cas9 editing. Our results show a critical function of NF2 for the maintenance of a stable pluripotent state. However, we were able to nudge them towards the Neural Crest-Schwann Cell (NC-SC) axis by applying a 3D Schwann cell differentiation protocol. NF2(+/-) and NF2(-/-) spheroids homogeneously expressed classical markers of the NC-SC lineage. In addition, NF2(-/-) SC-like spheroids showed dysregulation of multiple signaling pathways already described for merlin-deficient SC, and altered in human schwannomas. Therefore, NF2(+/-) and NF2(-/-) SC-like spheroids can represent a bona fide human in vitro cellular model to study the role of NF2 pathogenesis.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NF2 lacking exon 11 isoform induced by antisense gene therapy is able to recover partially merlin deficiency on NF2-related Schwannomatosis iPSC-derived spheroid model
Gemma Casals-Sendra, Ignasi Jarne-Sanz, … Elisabeth Castellanos·Molecular Therapy — Nucleic AcidsPeer-reviewed·Aug 3, 2026
- Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated Schwann cell proliferation in human.
Pei-Ciao Tang, Se Young Um, … Xue Zhong Liu·Stem Cell Research & TherapyPeer-reviewed·Apr 5, 2025
- Cellular mechanisms of heterogeneity in NF2-mutant schwannoma
C. C. MacKenzie, J. Vitte, … A. I. McClatchey·bioRxiv·Dec 31, 2020
- Merlin restoration prevents schwannoma progression in a genetically engineered mouse model of NF2-SWN
Jérémie Vitte, Christine Chiasson-MacKenzie, … Marco Giovannini·bioRxiv·Sep 16, 2026
- A novel induced pluripotent stem cell model of schwann cell differentiation reveals NF2-related gene regulatory networks of the extracellular matrix
Olivia Lazaro, Sihong Li, … Steven D. Rhodes·bioRxiv·May 2, 2024
- Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2
Desingu Ayyappa Raja, Yuanyun Huang, … Marianne E. Bronner-Fraser·bioRxiv·Apr 23, 2024